Deal Advisory for Private Equity & Executive Search in Healthcare Logistics, Parcel & Last-Mile
Helping PE firms and executive search firms make faster, better-informed decisions in complex, regulated logistics markets.
Former UPS Healthcare Strategy Director • Commercial Due Diligence • Portfolio Value Creation • Executive Assessment Support
Why JP Strategies
Practitioner-Led Insight for Complex Markets
JP Strategies advises private equity firms and executive search firms navigating healthcare logistics, parcel & last-mile, and complex transportation markets.
For investors, that means assessing market attractiveness, competitive dynamics, and operational risk — insight built to change deal terms, not just inform them.
For search firms, it means validating whether a candidate's operating experience actually holds up against the realities of healthcare logistics and regulated supply chains.
The firm brings a practitioner-led perspective — over 30 years operating inside global logistics, including leading the deployment of UPS Premier, a cold chain platform for biologics and specialty pharma across 50 countries — grounded in real-world execution, not external analysis alone.
Advisory Focus Areas
Healthcare Logistics
Strategic insight into cold chain logistics, radiopharmaceuticals, biologics, and complex healthcare transportation networks.
Cold-chain and temperature-sensitive logistics
Radiopharma and specialty healthcare distribution
Healthcare logistics market assessments
Logistics provider evaluation and strategic diligence
Healthcare supply chain strategy
Parcel & Last-Mile
Insight into the operational and competitive forces shaping parcel transportation, last-mile delivery, carrier strategy, and modern fulfillment networks.
Parcel and last-mile market dynamics
Carrier pricing and network strategy
Regional carrier ecosystem analysis
E-commerce fulfillment trends
Transportation industry diligence and assessments
Commercial Strategy
Advisory support for market assessments, commercial due diligence, growth strategy, product commercialization, and go-to-market decision-making in complex industries.
Commercial due diligence
Market assessments and competitive analysis
Growth strategy development
Product commercialization
Go-to-market strategy
Representative Experience
UPS® Premier Healthcare Logistics Platform
Led strategic and commercial initiatives supporting UPS Healthcare’s IoT-enabled cold chain visibility and intervention platform for time- and temperature-sensitive healthcare shipments.
Parcel & Last-Mile Strategy
Experience across parcel carrier strategy, regional delivery networks, e-commerce fulfillment trends, pricing dynamics, and transportation market assessments.
Product Innovation & Commercial Strategy
Led cross-functional initiatives involving product commercialization, market positioning, customer-focused innovation, and go-to-market strategy within a Fortune 50 environment.
Healthcare Logistics & Cold Chain Advisory
Advising investors, consulting firms, and executive teams on radiopharmaceutical supply chains, GDP-sensitive transportation networks, cold chain operations, and healthcare supply chain market dynamics.
Commercial Due Diligence & Market Assessments
Supporting investor and advisory teams evaluating logistics, transportation, healthcare supply chains, and operationally intensive business models.
Typical Engagements Include
Private Equity Firms • Executive Search Firms
Insights
Original market analysis on Precision Logistics, healthcare supply chains, and parcel market dynamics — written for investors, deal teams, and executive search firms.
Over-Monitored and Under-Coordinated: Why Pharma Logistics Needs a Trusted Source of Record.
Every critical therapy that reaches a patient at home represents a logistics chain that performed without failure. When that chain breaks down, it isn't a supply chain inconvenience. It is a clinical failure.
Read More →
The Supply Chain Behind Radiopharmaceuticals: What Investors Need to Know
The logistics infrastructure behind radiopharmaceuticals is one of the most demanding — and least understood — supply chains in healthcare. Understanding what it actually takes to move these products is increasingly relevant to diligence and thesis development.
Read More →
The Parcel Market Is Splitting in Two. Most Investment Theses Haven't Caught Up.
The U.S. parcel market is bifurcating into Commerce Logistics and Precision Logistics — two fundamentally different businesses with different competitive dynamics, different moats, and different investment questions.
Read More →
Working on a deal or search in this space? Let's talk.
Share a brief overview of your inquiry, including your company and role, and I will follow up directly to continue the conversation.